FDA Approves Novel Therapy for Newly Diagnosed AML. The FDA has approved Daiichi Sankyo’s Vanflyta (quizartinib) to treat adult patients with …
FDA Updates for the Week of July 17, 2023
Share This Story, Choose Your Platform!
About the Author:
FDA Approves Novel Therapy for Newly Diagnosed AML. The FDA has approved Daiichi Sankyo’s Vanflyta (quizartinib) to treat adult patients with …